Moshe Baru

492 total citations
18 papers, 384 citations indexed

About

Moshe Baru is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Moshe Baru has authored 18 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in Moshe Baru's work include Platelet Disorders and Treatments (6 papers), Hemophilia Treatment and Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Moshe Baru is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Hemophilia Treatment and Research (6 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Moshe Baru collaborates with scholars based in Israel, Russia and Belgium. Moshe Baru's co-authors include Israel Nur, Rivka Yatuv, Yechezkel Barenholz, Jonathan H. Axelrod, Michal Harel, Keren Turjeman, Rina Ulmansky, Yaakov Naparstek, Anna Ostropolets and Hanna Jaaro and has published in prestigious journals such as Journal of Virology, Journal of Controlled Release and Gene.

In The Last Decade

Moshe Baru

18 papers receiving 367 citations

Peers

Moshe Baru

HEMAT

GENET

ONCOL

BIOMA

Magdalena Bieniasz United States

Subhendu Mukhopadhyay United States

Keiji Kurata Japan

Catherine Carmichael Australia

Anna E. Marneth United States

Juana Serrano‐López Spain

F. A. Bennett Australia

Dietmar Seiffert United States

Chia Lin Chu United States

Michael Burke United States

Magdalena Bieniasz United States

Moshe Baru

224 ×1.3

34 ×0.2

HEMAT

39 ×0.7

GENET

99 ×1.9

ONCOL

27 ×0.6

BIOMA

Citations per year, relative to Moshe Baru Moshe Baru (= 1×) peers Magdalena Bieniasz

Countries citing papers authored by Moshe Baru

Since Specialization

Citations

This map shows the geographic impact of Moshe Baru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Baru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Baru more than expected).

Fields of papers citing papers by Moshe Baru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Baru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Baru. The network helps show where Moshe Baru may publish in the future.

Co-authorship network of co-authors of Moshe Baru

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Baru. A scholar is included among the top collaborators of Moshe Baru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Baru. Moshe Baru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bax, Bridget E., Michelle Levene, Murray Bain, et al.. (2019). Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial. Journal of Clinical Medicine. 8(8). 1096–1096. 43 indexed citations

Ulmansky, Rina, Keren Turjeman, Moshe Baru, et al.. (2011). Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. Journal of Controlled Release. 160(2). 299–305. 72 indexed citations

Spira, Jack, et al.. (2010). Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study. Haemophilia. 16(6). 910–918. 15 indexed citations

Yatuv, Rivka, et al.. (2010). Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF. Expert Opinion on Drug Delivery. 7(2). 187–201. 12 indexed citations

Baru, Moshe. (2010). The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia. International Journal of Nanomedicine. 5. 581–581. 22 indexed citations

Baru, Moshe, et al.. (2009). Enhancement of haemostatic efficacy of plasma‐derived FVIII by formulation with PEGylated liposomes. Haemophilia. 15(5). 1006–1013. 12 indexed citations

Yatuv, Rivka, et al.. (2008). Binding of proteins to PEGylated liposomes and improvement of G-CSF efficacy in mobilization of hematopoietic stem cells. Journal of Controlled Release. 135(1). 44–50. 12 indexed citations

Yatuv, Rivka, et al.. (2008). Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes. Haemophilia. 14(3). 476–483. 26 indexed citations

Yatuv, Rivka, et al.. (2006). A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C). Haemophilia. 12(3). 253–257. 8 indexed citations

10.

Barenholz, Yechezkel, et al.. (2005). Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy. Thrombosis and Haemostasis. 93(6). 1061–1068. 49 indexed citations

11.

Baru, Moshe. (2003). Size exclusion chromatography on soft and semi-rigid packing materials in the dynamic axial compression mode. Journal of Biochemical and Biophysical Methods. 57(2). 115–142. 3 indexed citations

12.

Otsuka, Masayuki, et al.. (2000). In VivoLiver-Directed Gene Transfer in Rats and Pigs with Large Anionic Multilamellar Liposomes: Routes of Administration and Effects of Surgical Manipulations on Transfection Efficiency. Journal of drug targeting. 8(4). 267–279. 19 indexed citations

13.

Baru, Moshe, et al.. (1998). Lysosome-disrupting Peptide Increases the Efficiency ofIn-vivoGene Transfer by Liposome-encapsulated DNA. Journal of drug targeting. 6(3). 191–199. 13 indexed citations

14.

Baru, Moshe, Jonathan H. Axelrod, & Israel Nur. (1995). Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice. Gene. 161(2). 143–150. 34 indexed citations

15.

Baru, Moshe, et al.. (1995). Retroviral-Mediated in vivo Gene Transfer into Muscle Cells and Synthesis of Human Factor IX in Mice. Intervirology. 38(6). 356–360. 6 indexed citations

16.

Baru, Moshe, et al.. (1992). Induction of polyomavirus DNA replication by carcinogens in polyomavirus-transformed rat cells: evidence that the viral enhancer is not the primary target in the induction pathway. Journal of Virology. 66(2). 1261–1266. 1 indexed citations

17.

Baru, Moshe, et al.. (1991). The yeast GAL4 protein transactivates the polyomavirus origin of DNA replication in mouse cells. Journal of Virology. 65(7). 3496–3503. 33 indexed citations

18.

Baru, Moshe, et al.. (1988). Induction of polyomavirus DNA replication by cyclic AMP and a tumor promoter.. PubMed. 29(6). 328–33. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact